Opdivo

Opdivo®

Opdivo® (nivolumab) is a prescription medicine administered by intravenous infusion for treatment of 12 different types of cancer by working with your immune system.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

MANUFACTURER:

Bristol-Myers Squibb

CLASS:
Biologic IV Infusion
WHAT IT TREATS:

Cancer

PRESCRIBED BY:

Oncologists

HOW ADMINISTERED:
Infusion
FREQUENCY:

Every 4 to 6 weeks

Length of infusion:
30 mins